Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma Miguel Lemaire, Janine Arts, et al. Cancer Res 2009;69:5307-5311
The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor,on the development of multiple myeloma in the 5T2MM and 5T33MM murine models S Deleu,M Lemaire,et al. Leukemia 2009;23:1894–1903
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.